ClinicalTrials.gov
ClinicalTrials.gov Menu

Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00745914
Recruitment Status : Completed
First Posted : September 3, 2008
Last Update Posted : January 10, 2017
Sponsor:
Information provided by (Responsible Party):
Dr. Angela Yee-Moon Wang, The University of Hong Kong

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2013
  Actual Study Completion Date : December 2013